SCHEMBL25625249

SCHEMBL25625249

CC(C)(C)c1cc2ccn(CC(C)(C)c3cc4cc[nH]c4nc3CC3CNC3)c2nc1CN1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25627937 0.82 CNR2 (0.30) —
SCHEMBL25627935 0.79 PIK3CA (0.31) —
SCHEMBL25613146 0.79 CACNA1G (0.34) —
SCHEMBL25613148 0.79 KDM4E (0.38) —
SCHEMBL25613161 0.76 KDM4E (0.40) —
SCHEMBL25650791 0.75 PIK3CA (0.31) —
SCHEMBL25613158 0.72 MAP3K11 (0.36) —
SCHEMBL25613162 0.71 HRH4 (0.37) —
SCHEMBL25613160 0.69 ALOX15 (0.41) —
SCHEMBL25613150 0.67 ULK1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159527-A1 COMPOUNDS AS BCL-2 INHIBITORS FOCHON BIOSCIENCES, LTD. (CN) 2023-05-25 — — US disclosed
Send feedback